The DNA Binding Domains of P1 ParB and the Architecture of the P1 Plasmid Partition Complex*

Jennifer A. Surtees and Barbara E. FunnellDagger

From the Department of Molecular and Medical Genetics, University of Toronto, Toronto, Ontario M5S 1A8, Canada

Received for publication, October 13, 2000, and in revised form, December 20, 2000



    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Stable maintenance of P1 plasmids in Escherichia coli is mediated by a high affinity nucleoprotein complex called the partition complex, which consists of ParB and the E. coli integration host factor (IHF) bound specifically to the P1 parS site. IHF strongly stimulates ParB binding to parS, and the minimal partition complex contains a single dimer of ParB. To examine the architecture of the partition complex, we have investigated the DNA binding activity of various ParB fragments. Gel mobility shift and DNase I protection assays showed that the first 141 residues of ParB are dispensable for the formation of the minimal, high affinity partition complex. A fragment missing only the last 16 amino acids of ParB bound specifically to parS, but binding was weak and was no longer stimulated by IHF. The ability of IHF to stimulate ParB binding to parS correlated with the ability of ParB to dimerize via its C terminus. Using full and partial parS sites, we show that two regions of ParB, one in the center and the other near the C terminus of the protein, interact with distinct sequences within parS. Based on these data, we have proposed a model of how the ParB dimer binds parS to form the minimal partition complex.



    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The P1 prophage exists as a low copy number plasmid in Escherichia coli, and its active partition system ensures that P1 is stably maintained in a bacterial population. The P1 par operon encodes two trans-acting factors, ParA and ParB, and a cis-acting centromere-like site, parS. Analogous systems exist in a number of low copy number plasmids, and the genes for homologues of both ParA and ParB have been identified in the chromosomes of several bacterial species (1-7).

Both ParA and ParB are required for and have multiple functions in partition. ParB binds specifically to the parS site (8, 9), along with E. coli integration host factor (IHF).1 Together, these two proteins bend and wrap the DNA into a structure called the partition complex (10-13). Bright, localized foci of ParB bound to parS in vivo have been visualized by immunofluorescence (14). ParA is an ATPase and binds the par operator region, repressing parA and parB expression (15). ParA also interacts directly with ParB bound at parS in an ATP-dependent manner (16). ParA is required for proper localization of the ParB-parS complexes (14), although it is not known how ParA promotes positioning of these complexes.

The plasmid centromere, parS, is a multipartite DNA site. An IHF binding site is flanked by two types of distinct sequences, called box A and box B, which are specifically recognized by ParB (11, 13) (Fig. 1A). Previous mutational and deletion analyses have shown that the presence and relative spacing of boxes A2, A3, B1, and B2 are essential for wild-type parS function in vivo, while boxes A1 and A4 are dispensable (11, 13, 17). ParB and IHF enhance each other's affinity for parS (12, 17). IHF binding creates a large bend in parS (12), and an inherently bent DNA sequence can partially substitute for the IHF site in parS (18). One dimer of ParB binds across the IHF-directed bend in parS (19), forming a structure in which the DNA is wrapped around the protein core (10, 12, 19). Subsequent dimers load onto the partition complex with increasing ParB concentrations via a series of protein-protein interactions and specific and nonspecific protein-DNA interactions that tether increasing amounts of ParB to the partition complex.

Two independent self-association domains have been identified within ParB (Fig. 2A) (20). One domain is located within the last 59 amino acids of ParB and is probably the domain that mediates dimerization in solution. The second domain is located near the N terminus of the protein. Our observations suggested that this domain is involved in oligomerization (i.e. dimer-dimer interactions) but that some type of conformational change in ParB is required for oligomers to form (20). First, the N terminus of ParB is relatively susceptible to proteolysis, suggesting that it is not very stably folded in solution. Second, self-association of the N terminus, measured by chemical cross-linking experiments in vitro, was observed only when the C-terminal half of ParB was removed. One possibility is that DNA binding elicits a conformational change that removes the inhibitory effect of the C terminus on N-terminal self-association, promoting oligomerization (20). The N-terminal oligomerization domain either overlaps or is adjacent to a region of ParB that is required for an interaction with ParA (Fig. 2A) (20, 21).

Previously we began to define the structural domains of ParB by identifying stable fragments generated by limited exposure to trypsin (20). Tryptic digestion resulted in fragments with increasingly C-terminal start sites (Fig. 2A, arrows) that extended to, or close to, the C terminus of ParB. The two longest lived fragments started at residues 142 and 185, respectively (Fig. 2A, arrows C and D). These results suggested that the C-terminal dimerization domain forms the core of a very stably folded C-terminal half of ParB (20).

Two different regions of ParB appear to have a role in its specific DNA binding activity, one near the C terminus of ParB and the second in the middle of the protein (Fig. 2A). Point mutations near the C terminus disrupt DNA binding activity (22). Proteins with these mutations also fail to dimerize, and it has been suggested that lack of dimerization prevents DNA binding. These mutations all fall within the last 59 amino acids of ParB, a region that encompasses the C-terminal dimerization domain (20). This region also includes the "discriminator recognition sequence" (DRS), defined by domain-swapping experiments (23). When residues 281-302 of P1 ParB were swapped with the equivalent region of the ParB protein of P7, the resulting hybrid protein recognized P7 parS in an in vivo partition assay (23). The P7 parS site is very similar to P1 parS. The P1 and P7 box A sequences are interchangeable, but the box B sequences are not (24). Thus, the swapping experiment defined the DRS as a region that contacts box B sequences directly or promotes a fold that allows box B binding. Analysis of the ParB sequence identified a putative helix-turn-helix (HTH) motif, from residue 166 to 189, that has also been implicated in ParB's DNA binding activities (25). Point mutations located on either side of the putative HTH domain disrupt DNA binding activity (22). It has been proposed that this region of the protein binds the box A sequences in parS (23).

In this study, we have examined the interaction of ParB with its specific sequences in parS by asking how different regions of the protein contribute to its DNA binding activities. Our results suggest a model of how protein-DNA (ParB-box A and ParB-box B) and protein-protein (dimerization) interactions contribute to the architecture of the partition complex.


    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Bacterial Strains and Media-- E. coli DH5 (F- endA1 hsdR17 (rK-mK+) supE44 thi-1 recA1 gyrA96 relA1) was used for all plasmid constructions. E. coli BL21 (F- ompT hsdSB (rB-mB+) dcm gal) (lambda DE3, pLysS) (26) was used for fusion protein expression and purification. All bacterial cells were grown in LB medium or on LB plates (27). Ampicillin and chloramphenicol, when used, were present at 100 and 25 µg/ml, respectively.

Reagents and Buffers-- Sources for reagents were as follows: dithiobis(succinimidyl propionate) (DSP), bovine serum albumin, and guanidine hydrochloride (Sigma); imidazole and Bradford reagent (Bio-Rad). Enzymes for cloning were purchased from New England Biolabs or Roche Molecular Biochemicals.

Plasmid Construction-- The new constructs created for this work were generated by PCR and cloned into pET15b (Novagen), which encodes a hexahistidine tag. pJS10 (20) was used as the substrate for PCR amplification. To create the 142-333 ParB fragment, the region of parB encoding this portion was amplified by PCR. The upstream primer (5'-GCGCCATATGGACGTTCAGACAGCATTG) added a single Met residue upstream of residue 142. M13 forward primer was the downstream primer. This PCR fragment was gel-purified (QIAEX II), digested with NdeI and BamHI, and ligated into pET15b, creating pJS208. For 1-330, 1-325, and 1-317 ParB, the upstream primer (5'-GCGCATATGTCAAAGAAAAACAGACCAAC) incorporated an NdeI site at the start site. The downstream primers, 5'CGCGGGATCCTTACTTTTTATCGAGGCTC, 5'CGCGGGATCCTTACTTTCTAAGGATATGCCC, and 5'CGCGGGATCCTTACCTGTCGAGTTCTTCCTG, created stop codons in place of residues 331, 326, and 318, respectively, and created a BamHI site downstream of the stop codons. The NdeI-BamHI fragments were then cloned into pET15b, generating pJS207, pJS212, and pJS213.

To create the internal deletions of ParB, the region of parB encoding residues 185-333 was amplified using an upstream primer (5'-CGCGCTCGAGTGCTCTCCAGGCAGCGAGTG) that placed a XhoI site just upstream of codon 185 and the M13 forward primer. The resulting XhoI-BamHI fragment was cloned into pET15b to create pJS206. The regions encoding residues 1-142 and residues 1-165 were amplified with an upstream primer, 5'-GCGCATATGTCAAAGAAAAACAGACCAAC (placing an NdeI site at the start site), and a downstream primer, either 5'-CGCGCTCGAGTCTTTCGCTAAATTTTGCGC (creating an XhoI site just downstream of codon 142) or 5'-CGCGCTCGAGCCATCATTTTTCATTCGCAT (creating an XhoI site just downstream of codon 165). The NdeI-XhoI fragments were cloned into pJS206 to generate pJS210, encoding Delta 142-185 ParB, and pJS211, encoding Delta 166-185 ParB. This cloning strategy replaced the region between residues 143 and 185 or between residues 165 and 185 of ParB with two serine residues.

DNA Substrates-- The plasmids pBEF165 and pBEF166 contain the P1 parS sequence in opposite orientations in a modified pBluescript vector (12). For gel mobility shift assays with the intact parS site, pBEF165 was digested with either BamHI, yielding a 252-bp parS fragment, or XbaI, yielding a 132-bp parS fragment. The DNA fragments were labeled at their 3'-ends with [alpha -32P]dATP and DNA polymerase I large fragment and purified with phenol/chloroform extraction and ethanol precipitation (27). For DNase I footprinting reactions, DNA substrates were generated by digesting either pBEF165 or pBEF166 with BamHI and SmaI or BamHI and BglII, generating a 211- or 240-bp parS fragment, respectively. They were 32P-labeled at the 3'-end of the BamHI site. The fragments labeled on the upper strand (as drawn in Fig. 1A) were generated from pBEF165, and fragments labeled on the lower strand were generated from pBEF166.

Competitor fragments for the gel mobility shift assays were 270 bp in length and were generated by PCR from pALA207 (28). The parS-containing fragment was amplified using the primers 5'-CACTTGTGTGAATCCCTTTTC and 5'-CAGGAAGAACTCGACAGGATG. The nonspecific fragment was amplified with the primers 5'-GCCTCTTGCGGGATATCGTC and 5'-CTGTCGCAGCAGAGATGATG. The fragments were then purified from agarose gels.

The single site oligonucleotide substrates used for gel mobility shift assays are illustrated in Fig. 1B. The lower strand of each pair was labeled at the 5'-end with [gamma -32P]ATP and T4 polynucleotide kinase. The unincorporated nucleotide was removed by gel filtration or by ethanol precipitation. The labeled oligomers were then mixed with an equal amount of the appropriate upper strand oligomer in 100 mM NaCl, 10 mM MgCl2, 0.1 mM EDTA. The mixture was heated to 70 °C and was then allowed to cool slowly to room temperature, to allow the two strands to anneal.

DSP Cross-linking-- Protein samples were diluted to between 8 and 20 µg/ml in 50 mM HEPES-KOH (pH 7.5), 150 nM NaCl, 0.1 mM EDTA. DSP (20 mg/ml in dimethylformamide) was added to 0.1 mg/ml, and the mixtures were incubated at room temperature. To stop the cross-linking and precipitate the proteins, samples were mixed with an equal volume of 30% trichloroacetic acid, incubated on ice for 20 min, and centrifuged at 4 °C. The pellets were washed with acetone and resuspended in 20 µl of 62.5 mM Tris-HCl (pH 6.8), 2% SDS, 10% glycerol, 0.025% bromphenol blue. The samples were incubated at 90 °C for 3 min and were then analyzed by SDS-polyacrylamide gel electrophoresis.

Electrophoretic Mobility Shift Assays-- The standard reaction mixture (10 µl) contained 0.1 nM 32P-labeled parS substrate in 50 mM HEPES-KOH (pH 7.5), 100 mM NaCl, 10 mM MgCl2, 10% glycerol, 100 µg/ml bovine serum albumin, 100 µg/ml sonicated salmon sperm DNA, and 5 mM beta -mercaptoethanol. The mixtures were assembled on ice, incubated at 30 °C for 20 min, and analyzed by electrophoresis on 5% polyacrylamide gels in 90 mM Tris borate, 1 mM EDTA at 180 V for 3 h in a water-cooled gel apparatus. The gels were dried on Whatman DE81 paper and exposed either to film or to a PhosphorImager screen (Molecular Dynamics, Inc., Sunnyvale, CA). When the single site oligomers were used as substrates, 1 nM labeled substrates were used per assay, and the final salt concentration of each reaction was ~140 nM NaCl.

DNase I Protection Assays-- Standard 20-µl reaction mixtures contained 10-50 fmol of 32P-labeled substrate, 50 mM HEPES-KOH (pH 7.5), 100 mM NaCl, 10% glycerol, 100 µg/ml sonicated salmon sperm DNA, 100 µg/ml of bovine serum albumin, 10 mM MgCl2, 2 mM CaCl2, and 7 mM beta -mercaptoethanol. The mixtures were assembled on ice and incubated at 30 °C for 15 min. Bovine pancreatic DNase I was then added (1 µl of a 1 µg/µl solution). After 2 min at 30 °C, the reaction was stopped by the addition of 80 µl of 1.6 M ammonium acetate, 400 µg/ml sonicated salmon sperm DNA, and 0.1 M EDTA. After phenol/chloroform extractions of the mixtures, the DNA was precipitated with ethanol and resuspended in 4 µl of formamide dye (27).


    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In this work, we have examined the architecture of the partition complex by determining the DNA binding properties of various regions of ParB. ParB is 333 amino acids in length, and we previously examined its domain structure by partial proteolysis mapping and by the self-association activity of various ParB protein fragments (20). Here we have used several of those fragments to examine their interaction with the P1 parS site. All fragments contained a polyhistidine tag to facilitate purification. In addition, we have constructed six new versions of ParB (Fig. 2B). Our previous partial proteolysis experiments identified two tryptic fragments that were relatively resistant to further digestion. His-ParB-(142-333) (constructed here) and His-ParB-(187-333) (constructed previously (20)) correspond to these two tryptic fragments (Fig. 2A; Ref. 20). To examine the function of the extreme C terminus of ParB, we removed 3, 8, and 16 residues from its C terminus, generating His-ParB-(1-330), His-ParB-(1-325), and His-ParB-(1-317), respectively. Finally, we made two internal deletions of ParB that removed the HTH motif. The first removed only this predicted motif (residues 166-184), and the second removed residues 143-184, the region between the start sites of the two stable tryptic fragments mentioned above (Fig. 2B).

We first tested the dimerization activity of the new protein fragments in a cross-linking assay (Fig. 3). His-ParB-(142-333) and both proteins with internal deletions (His-ParB-(Delta 166-184) and His-ParB-(Delta 143-184)) were cross-linked to dimer-sized smears in the presence of DSP, a cross-linking reagent that reacts primarily with lysines. His-ParB-(1-330) and His-ParB-(1-325) were also able to dimerize, as determined by this assay (Fig. 3). His-ParB-(1-317), however, was not cross-linked, indicating that it is predominantly monomeric in solution. It behaves as His-ParB-(1-312) (Fig. 3), which we previously reported to not be cross-linked by DSP (20). Therefore, the region between residues 317 and 325 of ParB defines the C-terminal boundary of its dimerization domain. The abilities of previously isolated ParB fragments to dimerize are summarized in Fig. 2B (20).

The Region between Residues 142 and 325 Contains All Information Required for Binding to the Full parS Site-- In the presence of IHF, one dimer of ParB binds to parS in a very high affinity protein-DNA complex (12, 19). This interaction requires that ParB contact its specific recognition sequences on either side of the IHF-directed bend simultaneously (13). In the absence of IHF, ParB affinity for parS is much lower, and binding is primarily dependent on the box A and box B sequences on the right side of the IHF site (Fig. 1). Therefore, we can distinguish two types of ParB binding: the latter (low affinity), requiring specific contacts but not IHF, and IHF-stimulated DNA binding (high affinity), requiring both specific contacts and the IHF-directed bend in the DNA. In this work, we address the question of what regions of ParB contribute to the different aspects of ParB's DNA binding activities.



View larger version (22K):
[in this window]
[in a new window]
 
Fig. 1.   The P1 parS site. A, tall and short boxes outline the box A and box B sequences, respectively, and the black line shows the IHF binding site (12). B, synthetic 25-base pair oligomers used as substrates in gel mobility shift assays.

We first examined several C-terminal fragments of ParB (i.e. truncated from the N terminus) for their parS binding activity. Full-length ParB (or His-ParB in our assays), and three fragments, His-ParB-(47-333), His-ParB-(67-333), and His-ParB-(142-333), bound to parS, and this binding was stimulated by IHF (Fig. 4, A-C). The affinity of the different ParB fragments for parS differed, but the relative affinity of each ParB fragment for parS was much higher with IHF than without IHF. Therefore, the first 141 residues of ParB are not required for IHF-stimulated parS binding.

Next, we assessed the importance of the central portion of ParB in DNA binding. His-ParB-(187-333) and His-ParB-(275-333) contain both the C-terminal dimerization domains and the DRS but are missing the putative HTH domain located near the center of ParB (Fig. 2). Neither fragment had any parS binding activity, with or without IHF (Figs. 4D and 8 and data not shown). Therefore, a region N-terminal to residue 187 is required for stable parS binding in this assay. Since the first 141 residues were not required for binding (Fig. 4C), the region between amino acids 142 and 187, which includes the putative HTH motif, contains information required for DNA binding. We next examined the activity of ParB fragments lacking only this region, His-ParB-(Delta 166-184) and His-ParB-(Delta 143-184). Neither protein bound parS with or without IHF (Fig. 4, E and F), although some apparently nonspecific or unstable binding activity was observed at the highest protein concentrations. These results indicated that the central region of ParB is required for parS binding and the C-terminal DRS is not sufficient for stable parS binding.



View larger version (16K):
[in this window]
[in a new window]
 
Fig. 2.   The structural and functional domains of ParB. A, schematic diagram of ParB domains. The black regions represent the regions of ParB involved in protein-protein and protein-DNA interactions. HTH, a predicted HTH motif; DRS, a second region implicated in DNA binding (see the introduction). The dimerization and oligomerization domains are at the C and N termini, respectively. The N terminus also contains a region required for interactions with ParA. The arrows indicate the N terminus of fragments generated by tryptic cleavage of ParB. B, diagram of ParB fragments used in this study. The black regions of His-ParB are as in A. Dimerization activity, as determined by DSP cross-linking is indicated in the first column (this study and Ref. 20). The second column summarizes the ability of the ParB fragments to bind parS, and the third column indicates whether binding was stimulated by IHF. N/A, not applicable.

Finally, we were interested in the role of the C terminus of ParB in DNA binding. We deleted 3 and 8 residues from the C terminus of ParB and tested the resulting fragments of ParB for their ability to bind parS in the gel mobility shift assay. His-ParB-(1-330) and His-ParB-(1-325) both exhibited IHF-stimulated DNA binding (Fig. 4, G and H), and both were able to dimerize as judged by cross-linking assays (Fig. 3).



View larger version (81K):
[in this window]
[in a new window]
 
Fig. 3.   Cross-linking of His-ParB and of ParB fragments. His-tagged proteins were incubated with DSP at room temperature for 20 min and analyzed by electrophoresis through a 12% polyacrylamide gel. Lane M, size markers.

DNase I footprinting experiments showed that His-ParB, His-ParB-(47-333), His-ParB-(67-333), and His-ParB-(142-333) exhibited very similar patterns of protection of the parS sequence (Fig. 5A and data not shown). As predicted from the gel mobility shift experiments, these results indicate that the first 141 amino acids of ParB are not required for minimal partition complex formation. Neither His-ParB-(187-333) nor His-ParB-(275-333) provided any protection of parS from DNase I cleavage, also consistent with the results from the gel mobility shift assays (data not shown). Similarly, His-ParB-(Delta 143-184) and His-ParB-(Delta 166-184) afforded no protection from DNase I cleavage (data not shown).

Footprinting experiments with His-ParB-(1-330) produced a pattern of protection similar to that of His-ParB but with additional enhancements (Fig. 5, B and C). First, on the upper strand of parS, one band in box B1 was strongly enhanced. On the lower strand, one band near the center and one near the right boundary of the IHF binding site were strongly enhanced. These differences indicate changes in the geometry of the complex that make the minor groove more accessible to DNase I in these regions. These enhancements were not observed in the presence of His-ParB-(1-325), whose protection pattern was very similar to that of His-ParB.

C-terminal Dimerization Is Required for High Affinity parS Binding-- In contrast to the fragments with small C-terminal deletions, His-ParB-(1-317), His-ParB-(1-312), His-ParB-(1-293), and His-ParB-(1-274) bound parS, but a high protein concentration was required to observe binding (500-1000 nM), and little or no stimulatory effect by IHF was observed (Fig. 4, I and J, and data not shown). The IHF-insensitive binding is relatively weak, as is full-length ParB binding to parS in the absence of IHF (12). Therefore, removal of only 16 amino acids from the C terminus removed the ability of IHF to stimulate ParB's specific DNA binding activity. The appearance of IHF-insensitive binding correlated with the loss of dimerization activity (20) (Figs. 2 and 3). Note that the N-terminal fragments with IHF-insensitive binding activity retain the putative HTH domain. His-ParB-(1-317) and His-ParB-(1-312) also retain the DRS.



View larger version (70K):
[in this window]
[in a new window]
 
Fig. 4.   DNA binding activity of several ParB fragments in the presence and absence of IHF, measured in gel mobility shift assays. 32P-Labeled parS fragments were incubated with the ParB proteins and/or IHF, and the mixtures were analyzed by electrophoresis through a 5% polyacrylamide gel. The parS fragments were generated from BamHI (A, B, D, E, F, G, H, and J) or XbaI (C and I) digests of plasmid pBEF165, yielding 252- and 132-base pair substrates, respectively. The BamHI digest also generated a 120- and a 3040-base pair vector fragment. The XbaI digest created only one 3280-base pair vector fragment. IHF, when present, was 400 nM. The positions of free DNA (parS) and the IHF-parS (I) complexes are indicated. The concentrations of His-ParB and of all ParB truncations are shown as nM monomers. Note that the large vector fragment contains an IHF binding site. A, His-ParB and His-ParB-(47-333) in the presence or absence of IHF. B, His-ParB-(67-333) in the presence or absence of IHF. The same substrate was used in both panels, but the gel on the right was run further, and the small nonspecific fragment ran off the bottom of the gel. C, His-ParB-(142-333) in the presence and absence of IHF. D, His-ParB-(187-333) in the presence of IHF. E, His-ParB-(Delta 166-184) in the presence and absence of IHF. F, His-ParB-(Delta 143-184) in the presence and absence of IHF. G, His-ParB-(1-330) in the presence and absence of IHF. H, His-ParB-(1-325) in the presence and absence of IHF. I, His-ParB-(1-317) in the presence and absence of IHF. J, His-ParB-(1-312) in the presence and absence of IHF.

ParB fragments that exhibited IHF-insensitive DNA binding activity in a gel mobility shift assay showed no detectable protection patterns in parS in DNase I footprinting experiments (Fig. 5D and data not shown). This was unexpected, because we had expected to observe binding to at least the box A motifs, since these fragments retained the HTH motif. We concluded that the parS binding activity of these IHF-insensitive ParB fragments was too weak to be detectable in a DNase I footprinting assay. However, His-ParB-(1-317) did show evidence of a specific interaction with parS. The same enhancements observed in the presence of His-ParB-(1-330) were also observed with His-ParB-(1-317) (Fig. 5D).



View larger version (104K):
[in this window]
[in a new window]
 
Fig. 5.   DNase I footprinting of His-ParB and ParB fragments at parS. The upper and lower strands correspond to the upper and lower strands shown in Fig. 1. The DNA substrates were 211-bp (A and D) or 240-bp (B and C) DNA fragments that were 32P-labeled at the 3'-end of either the upper or lower strand. Protein-DNA complexes were treated briefly with DNase I (see "Experimental Procedures") and analyzed on 6% sequencing gels. IHF, when present, was at 400 nM. ParB concentrations are reported for monomers. On each gel, Maxam-Gilbert G > A sequencing reactions were included as markers. The box A, box B and IHF sites are shown beside each gel. A, protection of the upper strand of parS from DNase I digestion by His-ParB-(142-333) or His-ParB. B, protection of the upper strand of parS from DNase I by His-ParB-(1-325), His-ParB-(1-330), or His-ParB. C, protection of the lower strand of parS from DNase I by His-ParB or His-ParB-(1-330). The arrows indicate enhancements created by His-ParB-(1-330). D, protection of the upper strand of parS from DNase I digestion by His-ParB, His-ParB-(1-317), or His-ParB-(1-312). The arrow indicates the enhancement generated by His-ParB-(1-317).

We tested whether the IHF-insensitive binding activity was still specific for parS, using competition assays (Fig. 6). The ability of an N-terminal fragment of ParB to bind to a labeled parS substrate was challenged by a 270-bp unlabeled DNA fragment containing either the parS sequence or a nonspecific sequence. With both His-ParB-(1-317) and His-ParB-(1-312), the parS DNA was a better competitor than the nonspecific DNA, indicating that binding was specific (Fig. 6 and data not shown). All ParB fragments that bound parS also contained some nonspecific DNA binding activity, a property of the full-length protein (12).



View larger version (99K):
[in this window]
[in a new window]
 
Fig. 6.   Competition analysis of His-ParB-(1-317) binding to parS. The 32P-labeled DNA substrate was a BamHI restriction digest of pBEF165 and was present at 10 fmol/lane. The fragment containing parS was 252 bp (arrow). Increasing amounts of unlabeled 270-bp DNA fragments containing parS or nonspecific sequence (indicated above the lanes in fmol) were added to the reaction mixtures prior to the addition of His-ParB-(1-317) (at 1 µM monomer). No IHF was added, and the mixtures were analyzed by electrophoresis in a 5% polyacrylamide gel (see "Experimental Procedures").

N-terminal fragments smaller than His-ParB-(1-274) had no DNA binding activity (data not shown). His-ParB-(1-234) is not cross-linked by DSP, and His-ParB-(1-189) has some self-association activity through the N-terminal oligomerization domain (20). Neither fragment interacted with parS. Therefore, a region C-terminal to residue 234 is required for binding, and N-terminal self-association of the protein is not sufficient to promote DNA binding.

Binding to Individual Box A or Box B Sequences-- While the different DNA binding activities of the ParB fragments used in this study supported the hypothesis that the putative HTH and the DRS regions interact with box A and box B sequences, respectively, we asked whether we could demonstrate direct interactions to isolated box A and/or box B sequences. We designed synthetic oligomer (25-bp) substrates that contained only the box A inverted repeat (i.e. box A2-box A3), only a single box B sequence, or box A2 + A3 combined with box B1 ("box A/B"). The last substrate essentially represents the minimal parS site, from box A2 to B1, that is functional in vivo (17, 18, 29). As controls, we designed two nonspecific oligomer substrates. One contained the same sequence as the box B oligomer, except that the box B sequence itself was scrambled, and the second contained an unrelated 25-bp sequence (Fig. 1B). Binding to these oligomeric substrates by His-ParB or His-ParB fragments was weak and often produced smeary complexes. Nonetheless, we could compare binding of the box A/B substrate to that of the single site substrates, which provided additional insight into ParB's DNA binding activities.

ParB binds to the minimal parS site weakly but specifically, and this site can promote partition in vivo, although it is less efficient than the full wild-type site in the presence of IHF (10-12). We expected, and found, that His-ParB binding to isolated box A and box B sequences would be weaker than to the box A/B sequence (Fig. 7A). Nevertheless, it looked specific, since it was better than to either nonspecific oligonucleotide.



View larger version (95K):
[in this window]
[in a new window]
 
Fig. 7.   DNA binding activity of ParB fragments to oligomeric DNA substrates. The oligomeric DNA substrates are described in Fig. 1B. They were prepared as described under "Experimental Procedures," and the specific activities (cpm/pmol) of all substrates were the same. Increasing amounts of His-ParB and ParB fragments were incubated with each of the oligomeric substrates and analyzed by electrophoresis in a 5% polyacrylamide gel. Protein concentrations are shown as µM monomer. A, His-ParB; B, His-ParB-(142-333); C, His-ParB-(Delta 166-184); D, His-ParB-(1-330); E, His-ParB-(1-317).

We examined the binding of several ParB protein fragments to these oligonucleotide substrates. His-ParB-(142-333) exhibited much weaker binding to the single-site substrates than to the box A/B substrate (Fig. 7B). This result, consistent with the DNase I footprinting data (Fig. 5A), illustrates that His-ParB-(142-333) recognizes box A and box B sequences but that both are required for significant DNA binding activity. In contrast, His-ParB-(Delta 166-184) showed weak but detectable binding to the box B substrate, but not to the box A substrate (Fig. 7C). Notably, binding to the box B substrate was about the same as to the box A/B substrate, implying that only the box B sequence contributes to its specific DNA binding activity.

Both His-ParB-(1-330) and His-ParB-(1-317) bound to the box A/B substrate better than to either box A or box B substrate alone (Fig. 7, D and E). As shown also by gel mobility shift assays and DNase I footprinting assays (Figs. 4G and 5C), the removal of 3 amino acids from the C terminus of ParB did not affect its specific DNA binding activities, and His-ParB-(1-330) must contain both the box A and box B recognition domains of the protein. While His-ParB-(1-317) appeared to bind the box A substrate better than the box B substrate, the DNase I footprinting experiment shows an interaction of His-ParB-(1-317) with box B (the enhancements in Fig. 5D). We suggest that removal of 16 residues from the C terminus does not remove but it does destabilize the domain of ParB that recognizes box B. Without proper box B recognition, ParB binding is specific but weak, and it is insensitive to IHF (Figs. 4I and 6).

The Putative Helix-Turn-Helix Domain Can Function as a Monomer-- Our experiments indicate that a dimerized C terminus of ParB is necessary but not sufficient for IHF-stimulated DNA binding activity; ParB must contain both the C terminus (including the DRS) and the HTH for this activity. Since HTH domains often function as dimers (30), we asked whether this region in ParB must be dimerized via the C-terminal domain for ParB to bind parS. We formed heterodimers between native ParB (no histidine tag) and His-ParB-(275-333), at a 10:1 molar ratio, by denaturing and then slowly renaturing the protein mixture. This small C-terminal fragment of ParB is able to dimerize but has no DNA binding activity (Figs. 2B and 8A). To confirm that heterodimers were formed, a portion of the ParB/His-ParB-(275-333) mixture was purified by nickel affinity chromatography. The majority of the mixture was retained on the column (data not shown). ParB dimers that bound the column must contain at least one histidine tag and therefore must be present in the form of heterodimers.



View larger version (72K):
[in this window]
[in a new window]
 
Fig. 8.   ParB/His-ParB-(275-333) heterodimers bind to parS. A, DNA binding by His-ParB-(275-333), ParB homodimers, and ParB/His-ParB-(275-333) heterodimers in the presence of IHF. The proteins were incubated with a 132-bp parS fragment, and the reaction mixtures were analyzed by electrophoresis through a 5% polyacrylamide gel. The protein concentrations (as nM dimers) are indicated above each lane. The concentration of ParB/His-ParB-(275-333) heterodimers assumes that all ParB monomers are paired with a His-ParB-(275-333) fragment. When present, IHF was at 400 nM. To form ParB/His-ParB-(275-333) heterodimers, 25 µg of ParB and 65 µg of His-ParB-(275-333) (10-fold molar excess) were mixed, diluted in 100 µl of 6 M guanidine-HCl, 0.1 M NaH2PO4, 0.01 M Tris (pH 8.0), and then dialyzed against 300 ml of the same buffer for 4 h at 4 °C to denature both proteins. The proteins were renatured by successive dialysis steps against decreasing concentrations of guanidine HCl followed by a final dialysis against 50 mM sodium phosphate, pH 8.0, 300 mM NaCl, 7 mM beta -mercaptoethanol, 10% glycerol. Both His-ParB-(275-333) and ParB were denatured and renatured in separate dialysis bags as controls. To repurify the ParB/His-ParB-(275-333) mixture, half of the denatured/renatured mixture was purified over a 20-µl nickel-agarose affinity chromatography column (20). Bound protein was eluted with 500 mM imidazole. The arrows indicate the following complexes: IHF complex (I); IHF plus ParB complex 1 (I + B1); and IHF plus ParB/His-ParB-(275-333) complex 1 (I + (B/275)1). B, DNA binding by homo- and heterodimers in the absence of IHF. B1, ParB complex 1.

The renatured proteins were used in gel mobility shift assays (Fig. 8). In the presence of IHF (Fig. 8A), the ParB/His-ParB-(275-333) heterodimer mix formed a complex that migrated between the parS + IHF (I) complex and the parS + IHF + ParB (I + B1) complex (Fig. 8A). This intermediate complex (I + (B/275)1), represents heterodimers binding to parS. Therefore, a single putative HTH domain, in the presence of a dimerized C terminus is sufficient to allow IHF-stimulated parS binding. Native ParB dimer complexes were also produced from the mixture, even when the heterodimers had been repurified over a nickel affinity column. This suggested that homodimerization of native ParB occurred over the course of the experiment. Finally, no intermediate complexes were observed in the absence of IHF (Fig. 8B); only complexes of the size expected from full-length ParB were seen.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Assembly of the P1 partition complex first requires the binding of one dimer of ParB and one alpha /beta heterodimer of IHF to parS, forming a very high affinity protein complex. Previous biochemical experiments have shown that ParB simultaneously contacts its recognition sequences on both sides of the IHF-induced bend in the DNA (13). Here, we have used a series of ParB fragments to determine the role of different domains in parS binding activity and to position the different regions of ParB within the nucleoprotein complex. Our results show that dimerization of ParB is essential for the ability of IHF to stimulate ParB binding to parS. Therefore, the ParB-ParB interaction across the IHF-directed bend is at the dimerization interface. In addition, our data support the prediction that the ParB HTH region recognizes the box A motifs and that the DRS is part of the domain that recognizes the box B motifs. While ParB recognizes two distinct sequences with two distinct regions of the protein, both interactions are important to observe maximal parS binding activity.

Fig. 9 illustrates how we think one dimer of ParB interacts with and might be positioned on parS in the presence of IHF. His-ParB-(142-333) interacts with both the box A and box B sequences, and this interaction is stimulated by IHF. Therefore, His-ParB-(142-333) contains all of the information required for assembly of the minimal partition complex that contains one dimer of ParB. The putative HTH motif of ParB is required for stable binding to the intact parS site (Fig. 4, E and F) and is necessary for an interaction with a box A inverted repeat on an oligonucleotide substrate (Fig. 7C). In our model, the HTH region of each monomer interacts with a box A sequence in the A2-A3 inverted repeat, similar to a typical HTH protein such as the lambda  repressor. Our results also indicate that the C terminus is directly involved in box B binding and that the bend induced by IHF is unable to stimulate ParB binding to parS in the absence of the C-terminal dimerization domain of ParB (Fig. 4, I and J). These observations support our previous prediction that the dimerized C termini of a ParB dimer interact with both box B1 and B2 simultaneously at or near the dimerization interface (19).



View larger version (22K):
[in this window]
[in a new window]
 
Fig. 9.   Model of the minimal partition complex. A, schematic diagram of the regions of ParB that are involved in binding the box A and box B sequences of parS. The black bar at the top represents the minimal region sufficient for parS binding activity. Below the schematic diagram is the predicted secondary structure of ParB. The boxes indicate predicted loops, the arrows show predicted beta -sheets, and the cylinders denote predicted alpha -helices. Only structures predicted with greater than 82% probability are shown. B, model of a single ParB dimer in the partition complex. 142-333 ParB contains all of the information required for DNA binding; therefore, the N terminus is omitted from this diagram. The dimerized C termini hold the two box B sites together, effectively wrapping the DNA around the ParB dimer. The two HTH motifs bind the Box A2-A3 inverted repeat. The N terminus of ParB (not shown) would be available for dimer-dimer and ParA-ParB interactions.

Two observations suggest that dimerization and box B binding are at least partially separable functions. First, His-ParB-(1-317), a protein fragment that did not dimerize, was able to recognize the box B sequence, as evidenced by the enhancement observed in its DNase I footprint (Fig. 5C). Second, His-ParB-(1-317) binding to the oligomer substrates was enhanced by the presence of a box B sequence (Fig. 7E), supporting the idea that dimerization and box B binding are separable functions. However, we cannot exclude the possibility that a small amount of dimerization occurs in the presence of the DNA, particularly if this deletion has only partially destabilized the dimerization domain.

The Putative Helix-Turn-Helix Domain-- Based on sequence alignments, ParB has been predicted to contain a HTH domain between residues 166 and 187 (25). Secondary structure prediction of ParB by PHD (31, 32), shown schematically in Fig. 9A, indicates a high probability that a helix is formed between residues 169 and 174 and between residues 180 and 188 of ParB. Between these two helices is a gap that includes a glycine residue, a residue that is highly conserved in the turn region of a classical HTH motif (30). While our biochemistry does not provide any structural evidence for such a domain, we have shown that the region spanning this putative motif is required for native DNA binding activity.

Typically, HTH proteins, such as the lambda  repressor, bind their recognition sites as dimers (30). The arrangement of a ParB dimer interacting with boxes A2 and A3 resembles that of a typical HTH dimer interacting with an inverted repeat binding site. The formation of an IHF-stimulated complex by ParB/His-ParB-(275-333) heterodimers (Fig. 8) shows that the HTH region need not act as a dimer. However, binding of ParB/His-ParB-(275-333) heterodimers to parS was completely dependent on IHF. Therefore, in the absence of IHF, both HTH domains must be present. These results suggest that the relative importance of box A and box B sequences differs in complexes with and without IHF. Without IHF, both box A2 and A3 must be filled to promote binding, whereas with IHF, the box B sequences tethered at the dimerization interface can compensate for the loss of one HTH-box A interaction.

ParB-like proteins share only limited homology (5, 33, 34), but one thing that many have in common is a predicted HTH motif (25). Similarly, the sequences of the specific sites that have been identified to date are quite different, but all of the known sites contain an inverted repeat (8, 35-37). It will therefore be interesting to see whether these other proteins bind their cognate site in a manner similar to that of P1 ParB.

Higher Order Partition Complexes-- The minimal partition complex contains one dimer of ParB, but at higher protein concentrations additional dimers join the complex to form even higher order complexes (19). We have suggested that additional ParB dimers are stabilized by interactions between the N-terminal self-association domains in ParB as well as by protein-DNA interactions. DSP cross-linking experiments showed that this domain was in the N-terminal half of ParB, but yeast two-hybrid experiments narrowed this to within the N-terminal 61 residues (20). Both His-ParB and His-ParB-(47-333) formed higher order complexes in our experiments, while His-ParB-(67-333) did not, consistent with our model. However, His-ParB-(142-333) also appeared to form higher order complexes. We cannot tell whether there are additional self-association contacts that are more C-terminal to residue 142 of ParB or whether these higher order complexes are promoted only by protein-DNA interactions. Another possibility is that the N-terminal oligomerization domain is mainly involved in dimer-dimer interactions that mediate pairing of partition complexes. The role of this domain awaits further structural analyses of ParB in these higher order complexes.


    ACKNOWLEDGEMENTS

We thank Alan Davidson and Lori Frappier for critical reading of the manuscript.


    FOOTNOTES

* This work was supported by a University of Toronto Open Fellowship (to J. A. S.) and Grant MOP-37997 from the Canadian Institutes of Health Research (to B. E. F.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: Dept. of Molecular and Medical Genetics, University of Toronto, Toronto, Ontario M5S 1A8, Canada. Tel.: 416-978-1665; Fax: 416-978-6885; E-mail: b.funnell@utoronto.ca.

Published, JBC Papers in Press, January 9, 2001, DOI 10.1074/jbc.M009370200


    ABBREVIATIONS

The abbreviations used are: IHF, integration host factor; HTH, helix-turn-helix; DRS, discriminator recognition sequence; DSP, dithiobis(succinimidyl propionate); bp, base pair(s); PCR, polymerase chain reaction.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES


1. Williams, D. R., and Thomas, C. M. (1992) J. Gen. Microbiol. 138, 1-16[Medline] [Order article via Infotrieve]
2. Youngren, B., Radnedge, L., Hu, P., Garcia, E., and Austin, S. (2000) J. Bacteriol. 182, 3924-3928[Abstract/Free Full Text]
3. Gerdes, K., Moller-Jensen, J., and Jensen, R. B. (2000) Mol. Microbiol. 37, 455-466[CrossRef][Medline] [Order article via Infotrieve]
4. Ireton, K., Gunther, N. W., and Grossman, A. D. (1994) J. Bacteriol. 176, 5320-5329[Abstract]
5. Mohl, D. A., and Gober, J. W. (1997) Cell 88, 675-684[CrossRef][Medline] [Order article via Infotrieve]
6. Gal-Mor, O., Borovok, I., Av-Gay, Y., Cohen, G., and Aharonowitz, Y. (1998) Gene (Amst.) 217, 83-90[CrossRef][Medline] [Order article via Infotrieve]
7. Kim, H.-J., Calcutt, M. J., Schmidt, F. J., and Chater, K. F. (2000) J. Bacteriol. 182, 1313-1320[Abstract/Free Full Text]
8. Davis, M. A., and Austin, S. J. (1988) EMBO J. 7, 1881-1888[Abstract]
9. Funnell, B. E. (1988) J. Bacteriol. 170, 954-958[Medline] [Order article via Infotrieve]
10. Funnell, B. E. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 6657-6661[Abstract]
11. Davis, M. A., Martin, K. A., and Austin, S. J. (1990) EMBO J. 9, 991-998[Abstract]
12. Funnell, B. E. (1991) J. Biol. Chem. 266, 14328-14337[Abstract/Free Full Text]
13. Funnell, B. E., and Gagnier, L. (1993) J. Biol. Chem. 268, 3616-3624[Abstract/Free Full Text]
14. Erdmann, N., Petroff, T., and Funnell, B. E. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 14905-14910[Abstract/Free Full Text]
15. Davis, M. A., Martin, K. A., and Austin, S. J. (1992) Mol. Microbiol. 6, 1141-1147[Medline] [Order article via Infotrieve]
16. Bouet, J.-Y., and Funnell, B. E. (1999) EMBO J. 18, 1415-1424[Abstract/Free Full Text]
17. Funnell, B. E., and Gagnier, L. (1994) Biochimie (Paris) 76, 924-932[CrossRef][Medline] [Order article via Infotrieve]
18. Hayes, F., and Austin, S. (1994) J. Mol. Biol. 243, 190-198[CrossRef][Medline] [Order article via Infotrieve]
19. Bouet, J.-Y., Surtees, J. A., and Funnell, B. E. (2000) J. Biol. Chem. 275, 8213-8219[Abstract/Free Full Text]
20. Surtees, J. A., and Funnell, B. E. (1999) J. Bacteriol. 181, 5898-5908[Abstract/Free Full Text]
21. Radnedge, L., Youngren, B., Davis, M., and Austin, S. (1998) EMBO J. 17, 6076-6085[Abstract/Free Full Text]
22. Lobocka, M., and Yarmolinsky, M. (1996) J. Mol. Biol. 259, 366-382[CrossRef][Medline] [Order article via Infotrieve]
23. Radnedge, L., Davis, M. A., and Austin, S. J. (1996) EMBO J. 15, 1155-1162[Abstract]
24. Hayes, F., and Austin, S. J. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 9228-9232[Abstract]
25. Dodd, I. B., and Egan, J. B. (1990) Nucleic Acids Res. 18, 5019-5026[Abstract]
26. Studier, F. W., and Moffatt, B. A. (1986) J. Mol. Biol. 189, 113-130[Medline] [Order article via Infotrieve]
27. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , 2nd Ed. , Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
28. Abeles, A. L., Friedman, S. A., and Austin, S. J. (1985) J. Mol. Biol. 185, 261-272[Medline] [Order article via Infotrieve]
29. Martin, K. A., Davis, M. A., and Austin, S. (1991) J. Bacteriol. 173, 3630-3634[Medline] [Order article via Infotrieve]
30. Pabo, C. O., and Sauer, R. T. (1992) Annu. Rev. Biochem. 61, 1053-1095[CrossRef][Medline] [Order article via Infotrieve]
31. Rost, B., and Sander, C. (1993) J. Mol. Biol. 232, 584-599[CrossRef][Medline] [Order article via Infotrieve]
32. Rost, B., and Sander, C. (1994) Proteins 19, 55-77[Medline] [Order article via Infotrieve]
33. Motallebi-Veshareh, M., Rouch, D. A., and Thomas, C. M. (1990) Mol. Microbiol. 4, 1455-1463[Medline] [Order article via Infotrieve]
34. Hanai, R., Liu, R. P., Benedetti, P., Caron, P. R., Lynch, A. S., and Wang, J. C. (1996) J. Biol. Chem. 271, 17469-17475[Abstract/Free Full Text]
35. Ludtke, D. N., Eichorn, B. G., and Austin, S. J. (1989) J. Mol. Biol. 209, 393-406[Medline] [Order article via Infotrieve]
36. Mori, H., Mori, Y., Ichinose, C., Niki, H., Ogura, T., Kato, A., and Hiraga, S. (1989) J. Biol. Chem. 264, 15535-15541[Abstract/Free Full Text]
37. Lin, D. C.-H., and Grossman, A. D. (1998) Cell 92, 675-685[Medline] [Order article via Infotrieve]


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.